Concepedia

Author

Ken Logue

St. Clair College

Also Known As

K Logue, K. Logue, Ken Logue, Marina Klein

9

Publications

202

Citations

4

H-Index

0

Concepts

All Affiliations

St. Clair CollegeGlaxoSmithKline (United Kingdom)
KL

About

Ken Logue is an author at St. Clair College.

Ken Logue

×

3

Publications

186

Citations

3

H-Index

YearCitations

Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study

Benoît Trottier, Jordan E. Lake, Ken Logue,

Antiviral Therapy

2016

106

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

Rafael Campo, E DeJesus, U. Fritz Bredeek,

Clinical Infectious Diseases

2013

48

Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks

Federico Pulido, Vicente Estrada, J.G. Baril,

HIV Clinical Trials

2009

32

Page 1